Literature DB >> 19589398

Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD).

Olli Arjamaa1, Mikko Nikinmaa, Antero Salminen, Kai Kaarniranta.   

Abstract

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the elderly throughout the world. AMD is attributed to a complex interaction of genetic and environmental factors. It is characterized by degeneration involving the retinal photoreceptors, retinal pigment epithelium (RPE), and Bruch's membrane, as well as alterations in choroidal capillaries. Aging and age-associated degenerative diseases, such as AMD, are intimately associated with decreased levels of tissue oxygenation and hypoxia that may induce accumulation of detrimental RPE-associated deposits, inflammation and neovascularization processes in retina. Hypoxia-inducible factor (HIF) is the master regulator for hypoxia-induced cellular adaptation that is involved in NF-kappaB signaling and the autophagic protein clearance system. In this review, we discuss role of HIF in AMD pathology and as a possible therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589398     DOI: 10.1016/j.arr.2009.06.002

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  66 in total

Review 1.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

2.  Hypoxia and inflammation in the release of VEGF and interleukins from human retinal pigment epithelial cells.

Authors:  Olli Arjamaa; Vesa Aaltonen; Niina Piippo; Tamás Csont; Goran Petrovski; Kai Kaarniranta; Anu Kauppinen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-19       Impact factor: 3.117

3.  Concerted inhibition of HIF-1α and -2α expression markedly suppresses angiogenesis in cultured RPE cells.

Authors:  Takeshi Nakajima; Emi Nakajima; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Mol Cell Biochem       Date:  2013-07-20       Impact factor: 3.396

4.  Autophagy and KRT8/keratin 8 protect degeneration of retinal pigment epithelium under oxidative stress.

Authors:  Ahruem Baek; Soojin Yoon; Jean Kim; Yu Mi Baek; Hanna Park; Daehan Lim; Hyewon Chung; Dong-Eun Kim
Journal:  Autophagy       Date:  2017-01-03       Impact factor: 16.016

Review 5.  Endoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularization.

Authors:  Antero Salminen; Anu Kauppinen; Juha Mt Hyttinen; Elisa Toropainen; Kai Kaarniranta
Journal:  Mol Med       Date:  2010-07-27       Impact factor: 6.354

Review 6.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases.

Authors:  Chung-Jung Chiu; Allen Taylor
Journal:  Prog Retin Eye Res       Date:  2010-09-22       Impact factor: 21.198

7.  Implications of DNA leakage in eyes of mutant mice.

Authors:  Alexander J Ogilvy; Defen Shen; Yujuan Wang; Chi-Chao Chan; Mones S Abu-Asab
Journal:  Ultrastruct Pathol       Date:  2014-06-25       Impact factor: 1.094

Review 8.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

9.  Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway.

Authors:  C H Lin; C H Li; P L Liao; L S Tse; W K Huang; H W Cheng; Y W Cheng
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization.

Authors:  Mingkai Lin; Yang Hu; Ying Chen; Kevin K Zhou; Ji Jin; Meili Zhu; Yun-Zheng Le; Jian Ge; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-14       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.